Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Illumina Inc
Illumina Inc
Activities:
Research & Development
X
LinkedIn
Trending Articles
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Precision psychiatry in action: How IMed Consultancy helped HMNC Brain Health’s Cortibon programme
AI-driven approach promises a new class of depression treatment
IMA Ilapak Doytronic 120 wins Oscar de l’Emballage 2024 award
Innovative stand-up pouch machine recognised for primary packaging excellence
You need to be a subscriber to read this article.
Click here
to find out more.
Creating a framework to measure the impact of drug delivery devices
Alex Fong, Insights and Sustainability Lead at Owen Mumford, discusses the company’s lifecycle assessment (LCA) journey
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Upcoming event
CPhI Middle East
10–12 December 2024 | Conference | Riyadh, Saudi Arabia
See all
Related Content
Research & Development
Almac expands sequencing capabilities through llumina instrument
Almac has purchased and installed an llumina NovaSeq X Plus instrument in Northern Ireland, which is set to expand its next generation sequencing capabilities for BioPharma partners
Regulatory
CMA challenges major genetic sequencing merger
The CMA has provisionally concluded that Illumina’s acquisition of Pacific Biosciences of California would result in a ‘substantial lessening of competition’
Research & Development
IDT partners with Illumina for NGS library preparation
Leaders in NGS tools collaborate to deliver robust multiplexing capabilities and streamline target enrichment methods
Research & Development
Almac to collaborate with Illumina on next-generation sequencing-based companion diagnostic development
The partnership with Illumina will provide an additional platform for the delivery of complex assays, expanding the options available to Almac partners
Design & Build
BioMed Realty and Illumina announce new build-to-suit laboratory building in Cambridge, UK
New state-of-the-art building to be located in scientific research park and will serve as Illumina's new European headquarters
Research & Development
Merck Serono and Illumina enter collaboration for diagnostics in oncology
Will develop assays that detect and measure multiple genetic variants in a single tumour sample to support clinical trials
Research & Development
Scotland to be at forefront of gene-led healthcare in £15m project with Illumina
Scottish Genomes Partnership will include Universities of Edinburgh and Glasgow
Subscribe now